Slit2 Suppresses Endothelial Cell Proliferation and Migration by Inhibiting the VEGF-Notch Signaling Pathway

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2017 Mar 6

PMID 28260032

Citations 17

Authors

Guo-Jian Li

Yong Yang

Guo-Kai Yang

Jia Wan

Dao-Lei Cui

Zhen-Huan Ma

Ling-Juan DU

Gui-Min Zhang

Affiliations

Soon will be listed here.

Abstract

Slit homolog 2 (Slit2) is distributed in various tissues and participates in numerous cellular processes; however, the role of Slit2 in the regulation of angiogenesis remains controversial, since it has previously been reported to exert proangiogenic and antiangiogenic activities. The present study aimed to investigate the effects of Slit2 on vascular endothelial cell proliferation and migration in vitro, and to reveal the possible underlying signaling pathway. Aortic endothelial cells were isolated from Sprague Dawley rats and cultured. Cell proliferation assay, cell migration assay, immunocytochemistry and small interfering RNA transfection were subsequently performed. The results demonstrated that exogenous Slit2 administration markedly suppressed TNF‑α‑induced endothelial cell proliferation and migration in vitro. In addition, TNF‑α application upregulated the protein expression levels of vascular endothelial growth factor (VEGF) and Notch in RAECs, whereas Slit2 administration downregulated VEGF and Notch expression in RAECs cultured in TNF‑α conditioned medium. Further studies indicated that knockdown of VEGF suppressed the effects of TNF‑α on the induction of RAEC proliferation and migration. VEGF knockdown‑induced inhibition of RAEC proliferation and migration in TNF‑α conditioned medium was also achieved without Slit2 administration. Furthermore, VEGF knockdown markedly decreased Notch1 and Notch2 expression. These results indicated that Slit2 suppresses TNF‑α‑induced vascular endothelial cell proliferation and migration in vitro by inhibiting the VEGF‑Notch signaling pathway. Therefore, Slit2 may inhibit the proliferation and migration of endothelial cells during vascular development.

Citing Articles

Methylome analysis of endothelial cells suggests new insights on sporadic brain arteriovenous malformation.

Scimone C, Donato L, Alibrandi S, Conti A, Bortolotti C, Germano A Heliyon. 2024; 10(15):e35126.

PMID: 39170526 PMC: 11336478. DOI: 10.1016/j.heliyon.2024.e35126.

Laminin 411 mediates endothelial specification via multiple signaling axes that converge on β-catenin.

Hall M, Givens S, Santosh N, Iacovino M, Kyba M, Ogle B Stem Cell Reports. 2022; 17(3):569-583.

PMID: 35120622 PMC: 9039757. DOI: 10.1016/j.stemcr.2022.01.005.

MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.

Rapanotti M, Cugini E, Nuccetelli M, Terrinoni A, Di Raimondo C, Lombardo P Int J Mol Sci. 2021; 22(22).

PMID: 34830300 PMC: 8623757. DOI: 10.3390/ijms222212416.

Molecular Mechanisms Underlying Remodeling of Ductus Arteriosus: Looking beyond the Prostaglandin Pathway.

Hsu H, Lin T, Liu Y, Yeh J, Hsu J Int J Mol Sci. 2021; 22(6).

PMID: 33810164 PMC: 8005123. DOI: 10.3390/ijms22063238.

Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma.

Suzuki T, Kano S, Suzuki M, Yasukawa S, Mizumachi T, Tsushima N Front Oncol. 2021; 10:603717.

PMID: 33692941 PMC: 7937931. DOI: 10.3389/fonc.2020.603717.

References

Tole S, Mukovozov I, Huang Y, Magalhaes M, Yan M, Crow M . The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils. J Leukoc Biol. 2009; 86(6):1403-15. DOI: 10.1189/jlb.0609391. View

Cao L, Arany P, Wang Y, Mooney D . Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling. Biomaterials. 2009; 30(25):4085-93. PMC: 2730921. DOI: 10.1016/j.biomaterials.2009.04.051. View

Kramer S, Kidd T, Simpson J, Goodman C . Switching repulsion to attraction: changing responses to slit during transition in mesoderm migration. Science. 2001; 292(5517):737-40. DOI: 10.1126/science.1058766. View

Liu D, Hou J, Hu X, Wang X, Xiao Y, Mou Y . Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation. Circ Res. 2006; 98(4):480-9. DOI: 10.1161/01.RES.0000205764.85931.4b. View

Morimoto M, Liu Z, Cheng H, Winters N, Bader D, Kopan R . Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J Cell Sci. 2010; 123(Pt 2):213-24. PMC: 2954246. DOI: 10.1242/jcs.058669. View

Piper M, Georgas K, Yamada T, Little M . Expression of the vertebrate Slit gene family and their putative receptors, the Robo genes, in the developing murine kidney. Mech Dev. 2000; 94(1-2):213-7. DOI: 10.1016/s0925-4773(00)00313-0. View

Kaur S, Castellone M, Bedell V, Konar M, Gutkind J, Ramchandran R . Robo4 signaling in endothelial cells implies attraction guidance mechanisms. J Biol Chem. 2006; 281(16):11347-56. DOI: 10.1074/jbc.M508853200. View

Ma W, Zhou Y, Lu D, Dong D, Tian X, Wen J . Reduced expression of Slit2 in renal cell carcinoma. Med Oncol. 2013; 31(1):768. DOI: 10.1007/s12032-013-0768-4. View

Jones C, Nishiya N, London N, Zhu W, Sorensen L, Chan A . Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity. Nat Cell Biol. 2009; 11(11):1325-31. PMC: 2854659. DOI: 10.1038/ncb1976. View

10.

Mukovozov I, Huang Y, Zhang Q, Liu G, Siu A, Sokolskyy Y . The Neurorepellent Slit2 Inhibits Postadhesion Stabilization of Monocytes Tethered to Vascular Endothelial Cells. J Immunol. 2015; 195(7):3334-44. DOI: 10.4049/jimmunol.1500640. View

11.

Waldner M, Neurath M . Targeting the VEGF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012; 16(1):5-13. DOI: 10.1517/14728222.2011.641951. View

12.

Qin F, Zhang H, Ma L, Liu X, Dai K, Li W . Low Expression of Slit2 and Robo1 is Associated with Poor Prognosis and Brain-specific Metastasis of Breast Cancer Patients. Sci Rep. 2015; 5:14430. PMC: 4585856. DOI: 10.1038/srep14430. View

13.

Park K, Morrison C, Sorensen L, Jones C, Rao Y, Chien C . Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Biol. 2003; 261(1):251-67. DOI: 10.1016/s0012-1606(03)00258-6. View

14.

Yoshida Y, Hayashi Y, Suda M, Tateno K, Okada S, Moriya J . Notch signaling regulates the lifespan of vascular endothelial cells via a p16-dependent pathway. PLoS One. 2014; 9(6):e100359. PMC: 4065107. DOI: 10.1371/journal.pone.0100359. View

15.

Gale N, Thurston G, Davis S, Wiegand S, Holash J, Rudge J . Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation. Cold Spring Harb Symp Quant Biol. 2003; 67:267-73. DOI: 10.1101/sqb.2002.67.267. View

16.

Hirashima M . Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling. Anat Sci Int. 2009; 84(3):95-101. DOI: 10.1007/s12565-009-0026-1. View

17.

Jones C, London N, Chen H, Park K, Sauvaget D, Stockton R . Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med. 2008; 14(4):448-53. PMC: 2875252. DOI: 10.1038/nm1742. View

18.

Chintala H, Krupska I, Yan L, Lau L, Grant M, Chaqour B . The matricellular protein CCN1 controls retinal angiogenesis by targeting VEGF, Src homology 2 domain phosphatase-1 and Notch signaling. Development. 2015; 142(13):2364-74. PMC: 4510592. DOI: 10.1242/dev.121913. View

19.

Gohrig A, Detjen K, Hilfenhaus G, Korner J, Welzel M, Arsenic R . Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer. Cancer Res. 2014; 74(5):1529-40. DOI: 10.1158/0008-5472.CAN-13-1012. View

20.

Alvarez C, Tapia T, Cornejo V, Fernandez W, Munoz A, Camus M . Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer. Mol Carcinog. 2012; 52(6):475-87. DOI: 10.1002/mc.21881. View